Clinical review report: Dapagliflozin (Forxiga)
The objective of this review was to perform a systematic review of the beneficial and harmful effects of dapagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, April 2016
|
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | The objective of this review was to perform a systematic review of the beneficial and harmful effects of dapagliflozin for the treatment of adults with type 2 diabetes who have experienced inadequate glycemic control on combination therapy with metformin and a sulfonylurea |
---|---|
Physical Description: | 1 PDF file (ix, 62 pages) illustrations |